| 產(chǎn)品名稱 |
FeLV-3281 |
| 商品貨號(hào) |
B164451 |
| Organism |
Felis catus, cat |
| Product Format |
frozen |
| Morphology |
lymphoblast |
| Culture Properties |
suspension |
| Biosafety Level |
2 Cells Contain PAPOVAVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Genes Expressed |
Feline leukemia virus (FeLV), subgroup A |
| Cellular Products |
Feline leukemia virus (FeLV), subgroup A |
| Complete Growth Medium |
RPMI 1640 medium with 4 mM L-glutamine and 0.025 mg/ml gentamicin sulfate, 90%; fetal bovine serum, 10%
|
| Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Cryopreservation |
Culture medium, 95%; DMSO, 5% |
| Name of Depositor |
Aquila Biopharmaceuticals, Inc. |
| U.S. Patent Number |
|
